Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D.
We love to hear from our listeners. Send us a message.
While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge S…
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
We love to hear from our listeners. Send us a message.
The concept of programmable biology is fueling a new breed of biotech, one that requires the marriage of computational and traditional science (…
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
We love to hear from our listeners. Send us a message.
Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continue…
Biotech Is Back with Allan Shaw
We love to hear from our listeners. Send us a message.
The Business of Biotech took a trip to San Francisco for the JP Morgan Healthcare Conference, that most target-richest of environments for those…
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins a…
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
We love to hear from our listeners. Send us a message.
We spend a lot of time talking with our guests about building biotech companies. That’s true of this episode too, but today we’re taking a step …
Art Of The Pivot with Elevation Oncology's Joe Ferra
We love to hear from our listeners. Send us a message.
Relatively new CEO Joseph Ferra has orchestrated some pretty significant change at Elevation Oncology in the two(ish) years since the Business o…
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
We love to hear from our listeners. Send us a message.
A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees…
Biotech Down Under with BiomeBank's Dr. Sam Costello
We love to hear from our listeners. Send us a message.
Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costell…
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, we welcome two extraordinary guests - Dr. Neela Patel, a molecular biologist-turned-Chief Bus…
Public Sector Forged, Private Sector Tested with Renovaro BioSciences' Mark Dybul, M.D.
We love to hear from our listeners. Send us a message.
During his leadership of the President's Emergency Plan for AIDS Relief during the George W. Bush administraion, Dr. Mark Dybul, M.D. shepherded…
mRNA Vaccine Platforms with Combined Therapeutics' Dr. Romain Micol
We love to hear from our listeners. Send us a message.
Combined Therapeutics President & CEO Dr. Romain Micol is operating his company in a very noisy space, where hundreds of new biotechs have poppe…
Biotech Dealmaking with Regeneron's Nouhad Husseini
We love to hear from our listeners. Send us a message.
When it comes to landing and executing strategic partnerships, Regeneron puts on a clinic. Partnerships, acquisitions, licensing agreements, and…
Backpacks And Biotech with Luke Timmerman
We love to hear from our listeners. Send us a message.
From his vantage point as an independent biotech journalist, Luke Timmerman has been watching the expansions and retractions of the industry for…
RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.
We love to hear from our listeners. Send us a message.
Earlier this year, Shawn Davis, Ph.D. left a pretty comfortable position at AstraZeneca (and Amgen before that, and Milliken, and others, before…
The Legendary Steve Gorlin's Golden Rules
We love to hear from our listeners. Send us a message.
Shortly after Thalidomide became a household word—albeit a very, very bad one—a biotech investor bought it for a couple hundred grand. Who on ea…
UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono
We love to hear from our listeners. Send us a message.
Register for Business of Biotech Live! Legal & IP Protection For New Biotechs here. Get ready to unravel the legal enigmas of the biotech world …
CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt
We love to hear from our listeners. Send us a message.
What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract develpment and manufa…
Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
We love to hear from our listeners. Send us a message.
On a road trip to Boston, the Business of Biotech caught up with podcast alum Dan Passeri, J.D., CEO at Cue Biopharma, and enjoyed a two-for-one…
Bio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.
We love to hear from our listeners. Send us a message.
Johanna Kaufmann, Ph.D.'s path to EVP, Oncology at Codagenix is part serendipity and part circumstance, but it's a much larger part hard work. O…